UBS Maintains a 'Neutral' on Complete Genomic (GNOM); Adjusting Numbers After Q1 Review
Tweet
Share
E-mailGet Alerts GNOM Hot Sheet
Price: $58.31 -1.27%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
UBS maintains a 'Neutral' on Complete Genomic (NASDAQ: GNOM) price target lowered from $4.00 to $3.00.
Analyst, Daniel Arias, said, "Shipments in line, but sales fall short on delayed revenue recognition...ASPs remain around $4k; clinical market access remains a focus...At qtr-end, backlog stood at 5,700 genomes (for ~$27M), with 2,000 genomes expected to ship in 2Q – up significantly from 1Q but below our prior 2,300 genome est. We now see ’12 sales of $32M- down from $34M, & loss per share of $2.18 (was ($2.16)). In ’13, we see sales of $52M & loss per share of $1.80 (from (1.70))."
For an analyst ratings summary and ratings history on Complete Genomic click here. For more ratings news on Complete Genomic click here.
Shares of Complete Genomic closed at $2.68 yesterday.
Analyst, Daniel Arias, said, "Shipments in line, but sales fall short on delayed revenue recognition...ASPs remain around $4k; clinical market access remains a focus...At qtr-end, backlog stood at 5,700 genomes (for ~$27M), with 2,000 genomes expected to ship in 2Q – up significantly from 1Q but below our prior 2,300 genome est. We now see ’12 sales of $32M- down from $34M, & loss per share of $2.18 (was ($2.16)). In ’13, we see sales of $52M & loss per share of $1.80 (from (1.70))."
For an analyst ratings summary and ratings history on Complete Genomic click here. For more ratings news on Complete Genomic click here.
Shares of Complete Genomic closed at $2.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Berenberg Upgrades Mobileye N.V (MBLY) to Buy
- JPMorgan Upgrades Resona Holdings, Inc (8308:JP) (RSNHF) to Overweight
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
